1. Home
  2. MODD vs BMRA Comparison

MODD vs BMRA Comparison

Compare MODD & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modular Medical Inc.

MODD

Modular Medical Inc.

N/A

Current Price

$1.96

Market Cap

11.2M

Sector

Health Care

ML Signal

N/A

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$2.32

Market Cap

11.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MODD
BMRA
Founded
1998
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2M
11.5M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
MODD
BMRA
Price
$1.96
$2.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 114.5K
32.3K
Earning Date
11-13-2026
10-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.81
EPS
★ N/A
N/A
Revenue
N/A
★ $4,453,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.12
$1.45
52 Week High
$6.16
$3.21

Technical Indicators

Market Signals
Indicator
MODD
BMRA
Relative Strength Index (RSI) 35.31 N/A
Support Level $1.72 N/A
Resistance Level $2.49 N/A
Average True Range (ATR) 0.21 0.00
MACD -0.04 0.00
Stochastic Oscillator 18.39 0.00

Price Performance

Historical Comparison
MODD
BMRA

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, marketing and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.

Share on Social Networks: